MMP-9 is known to degrade occludin and claudin-5 in focal cerebral ischemia [30], and it has been reported that it affects the expression of occludin, claudin-5, and ZO-1 and ZO-2 levels in early diabetic retinopathy [27,31,32]. This evidence concerns the gene CLDN5 and diabetic retinopathy.